Frontiers in Immunology

Original Research

Accepted on 09 Jun 2025

Enhancing Fibroblasts-Epithelial Communications: Serpine2 as a key Molecule in Fusobacterium nucleatum-Promoted Colon Cancer

in Cancer Immunity and Immunotherapy

Xueke Li
Simin Luo
Yifang Jiang
Qiong Ma
Fengming You
Qiquan Kuang
Xi Fu
Chuan Zheng

Frontiers in Immunology

doi 10.3389/fimmu.2025.1563922

Brief Research Report

Accepted on 09 Jun 2025

Sexual Dimorphism-Driven Differences Are Overcome in a Preclinical Vaccine Model Against Trypanosoma cruzi

in Vaccines and Molecular Therapeutics

Camila Bulfoni Balbi
Maria Florencia Pacini
Brenda Dinatale
Cecilia Farre
Paula Cacik
Estefanía Prochetto
Florencia Belén González
Iván Marcipar
Gabriel Cabrera
Ana Rosa Pérez

Frontiers in Immunology

doi 10.3389/fimmu.2025.1526573

Original Research

Accepted on 09 Jun 2025

Investigating the Role of Soil-Transmitted Helminth Infections in Leprosy Development in Leprosy Endemic Areas

in Microbial Immunology

Vikram Singh
Dr. Ravindra P. Turankar
Vinay Kumar Pathak
Itu Singh
Rahul Sharma
Anjana Goel
Utpal Sengupta

Frontiers in Immunology

doi 10.3389/fimmu.2025.1499304

Review

Accepted on 09 Jun 2025

The Potential Immunomodulatory Role of Human Milk Oligosaccharides in Prevention of Viral Infections and Development of Asthma in Early Life

in Nutritional Immunology

Vera Rijks
Marit Zuurveld
Johan Garssen
Atanaska I Kostadinova
Linette E.M. Willemsen

Frontiers in Immunology

doi 10.3389/fimmu.2025.1572787

Original Research

Accepted on 09 Jun 2025

PD-L1 Deficiency Exacerbates Colitis Severity by Remodeling Gut Microbiota in Inflammatory Bowel Disease

in Autoimmune and Autoinflammatory Disorders : Autoimmune Disorders

Yixian Ma
Jinshan Suo
Siqi Sheng
Ling Chen

Frontiers in Immunology

doi 10.3389/fimmu.2025.1622744

Case Report

Accepted on 09 Jun 2025

Cadonilimab Combined with Trastuzumab and Chemotherapy for HER2-Positive Gastric Cancer with Bone Marrow Metastasis and DIC: A Case Report and Literature Review

in Cancer Immunity and Immunotherapy

Gangling Tong
MeiJing Chen
JiWen Fan
DanYang Zhou
BoRan Cheng
ShuBin Wang

Frontiers in Immunology

doi 10.3389/fimmu.2025.1608636

Mini Review

Accepted on 09 Jun 2025

The differential role of IL-33 and IL-38 in prostate cancer, contradictory roles?

in Cancer Immunity and Immunotherapy

Runfen Ban
Shanshan Gao
Bin Zhou
Shisan (Bob) Bao

Frontiers in Immunology

doi 10.3389/fimmu.2025.1623038

Review

Accepted on 09 Jun 2025

Utilizing Plasma Exchange for Severe Cytokine Release Syndrome after CAR-T cell therapy: Clinical Experience and Literature Insights

in Cancer Immunity and Immunotherapy

Jiasi Zhang
dali Xie
meiyan tang
qiang Gong
xingqin Huang
ju Li
Shuangnian XU
nan Luo
huiling Sun
fangfang Tan

Frontiers in Immunology

doi 10.3389/fimmu.2025.1597512

Original Research

Accepted on 09 Jun 2025

STING regulates NETs formation by activating GSDMD in influenza viral pneumonia

in Viral Immunology

Rongrong Huang
Ranran Chen
Lijuan Xing
Lianhao Wu
Wenwen Zhu
Junsong Jing
Ting Zhou
Yueguo Wu
Sheng Zhang
Zhenqiang You

Frontiers in Immunology

doi 10.3389/fimmu.2025.1598902

Case Report

Accepted on 09 Jun 2025

A Rare Case Report: Immune Checkpoint Inhibitor-Induced Myositis Without Elevated Creatine Kinase

in Cancer Immunity and Immunotherapy

Klajdi Begaj
Raphael Wilhelm
Alisa Lepper
Jakob Veeser
Maike Kaufhold
Stephan Grabbe
Henner Stege

Frontiers in Immunology

doi 10.3389/fimmu.2025.1592385

Review

Accepted on 09 Jun 2025

Exosomal proteins: new targets for early diagnosis and treatment of cancer

in Cancer Immunity and Immunotherapy

Haibin Shen
Meijin Liu
Wentai Yang
Dewang Xiao
Zongbo Peng
Dingyu Rao
Defa Huang

Frontiers in Immunology

doi 10.3389/fimmu.2025.1613494

Original Research

Accepted on 09 Jun 2025

Multi-omics analysis reveals glutathione metabolism-related immune suppression and constructs a prognostic model in lung adenocarcinoma

in Systems Immunology

Yuxiang Chi
Guoyuan Ma
Qiang Liu
Yz X
Defeng Liu
Jiajun Du

Frontiers in Immunology

doi 10.3389/fimmu.2025.1608407

Original Research

Accepted on 09 Jun 2025

BRICS sequential therapeutic regimen as first-Line treatment for PD-L1-negative metastatic non-small cell lung cancer patients harboring EGFR/ALK wild-type status: a retrospective study

in Cancer Immunity and Immunotherapy

Jianxin Chen
Jian Wang
Weiqiang Fan
Yating Wu
Hang Li
Hui Xu
Yunyun Zhu
Yanran Cheng
Zongyang Yu
Yonghai Peng

Frontiers in Immunology

doi 10.3389/fimmu.2025.1618110

Original Research

Accepted on 09 Jun 2025

Response gene to complement 32 promotes tumorigenesis by mediating DNA damage repair and inhibits CD8+ T cells infiltration in diffuse large B-cell lymphoma

in Cancer Immunity and Immunotherapy

Xiyuan Zhang
Tiange Lu
Chunlei Shi
Mengfei Ding
Ling Wang
Xinting Hu
Xin Wang

Frontiers in Immunology

doi 10.3389/fimmu.2025.1591615

Original Research

Accepted on 09 Jun 2025

CD79A and GADD45A as Novel Immune-Related Biomarkers for Respiratory Syncytial Virus Severity in Children: An Integrated Machine Learning Analysis and Clinical Validation

in Systems Immunology

Juan Juan Chen
Zhang Ze Lu
Yuxin Jing
Na Lin
Mei Xing Nong
Yan Qin
Jie Wei
Jin Yang Huang

Frontiers in Immunology

doi 10.3389/fimmu.2025.1609183

Original Research

Published on 09 Jun 2025

Natriuretic peptides modulate monocyte-derived Langerhans cell differentiation and promote a migratory phenotype

in Antigen Presenting Cell Biology

Dorottya Horváth
Zsófia Pénzes
Petra Molnár
István Rebenku
György Vereb
Magdolna Szántó
Szabolcs Muzsai
Andrea Szegedi
Zsolt Dajnoki
Kitti Pázmándi

Frontiers in Immunology

doi 10.3389/fimmu.2025.1593141

187 views